Medical Writing Public Disclosure Writing lay summaries: What medical writers need to know
volume27-issue2png

Volume 27, Issue 2 - Public Disclosure

Writing lay summaries: What medical writers need to know

Abstract

Lay summaries are critical for building publictrust in clinical research and therefore forrecruiting patients. They are also an importantpart of efforts to improve data transparency.Due to new global regulations, lay summarieswill soon probably become mandatory for allclinical studies. Medical writers shouldtherefore be aware of the regulations andessential content of lay summaries. Using acase study of a published lay summary, thisarticle discusses best practices, including theappropriate target audience, language, anddata and visual presentation.

Download the full article

References

  1. Lo B. The Clinical Trial Life Cycle and When to Share Data. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington: National Academies Press; 2015.
  2. Getz K, Hallinan Z, Simmons D, Brickman MJ, Jumadilova Z, Pauer L, et al., Meeting the obligation to communicate clinical trial results to study volunteers. Expert Rev Clin Pharmacol. 2012;5(2):149–56.
  3. The Centre for Information and Study on Clinical Research Participation. Public and Patient Perceptions and Insights Study. Boston: CISCRP. [Cited 2018 March 12]. Available from: Available from: https://www.ciscrp.org/services/research-services/public-and-patient-perceptions-insights-study/
  4. World Medical Association. WMA Declaration of Helsinki – ethical principles for medical research involving human subjects. France: WMA. 2017. [Cited 2018 March 12]. Available from: Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
  5. European Medicines Agency (EMA). Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. UK: EMA. 2014. [Cited 2018 March 12]. Available from: Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf
  6. European Medicines Agency (EMA). Summaries of Clinical Trial Results for Laypersons. UK: EMA. 2018 [Cited 2018 March 12]. Available from: Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/2017_01_26_summaries_of_ct_results_for_laypersons.pdf
  7. European Medicines Agency (EMA). Clinical Trial Regulation. UK: EMA. [Cited 2018 March 12]. Available from: Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000629.jsp
  8. Federal Register. Clinical Trials Registration and Results Information Submission. 2016 [Cited 2018 March 12]. Available from: Available from: https://www.federalregister.gov/documents/2016/09/21/2016-22129/clinical-trials-registration-and-results-information-submission
  9. Gillow CL. Layperson summaries of clinical trial results: Useful resources in the vacuum of regulatory guidance. Medical Writing. 2015;24(4):205–9.
  10. The Center for Information and Study on Clinical Research Participation. Lay Language Summaries: Acknowledging leaders in patient engagement. Boston: CISCRP. [Cited 2018 March 12]. Available from: Available from: https://www.ciscrp.org/services/communicating-trial-results/
  11. TrialScope. Press Release: TrialScope Launches Trial Results Summaries Portal. New Jersey: TrialScope. 2017 [Cited 2018 March 12]. Available from: Available from: http://www.trialscope.com/trialscope-launches-trial-results-summaries-portal/
  12. CISCRP Clinical Trial Results Summaries. Pfizer-Lyrica. [Cited 2018 March 12]. Available from: Available from: https://www.ciscrp.org/download/nct01057693-pfizer-lyrica/?wpdmdl=4979
  13. Tassone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther. 2007;29(1):26–48.
  14. Raynor DK, Myers L, Blackwell K, Kress B, Dubost A, Joos A. Clinical trial results summary for laypersons: a user testing study. Ther Innov Regul Sci. 2018:2168479017753129.
  15. Barnfield S, Pitts AC, Kalaria R, Allan L, Tullo E. “Is all the stuff about neurons necessary?” The development of lay summaries to disseminate findings from the Newcastle Cognitive Function after Stroke (COGFAST) study. Res Involv Engagem. 2017;3:18.
  16. Buljan I, Malički M, Wager E, Puljak L, Hren D, Kellie F, et al. No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials. J Clin Epidemiol. 2017 Dec 18. pii: S0895–4356(17)30490–0.
  17. Sroka-Saidi K, Boggetti B, Schindler TM. Transferring regulation into practice: The challenges of the new layperson summary of clinical trial results. Medical Writing. 2015;24(1):24–7.

Search

Articles

Editorial
President’s Message
EMWA News
The Regulatory Public Disclosure Special Interest Group
Clinical trial disclosure and transparency
Clarity and Openness in Reporting: E3-based (CORE) Reference
Navigating the EMA clinical data website
Anonymisation reports from 2016 to 2017: A preliminary analysis
Preparing anonymisation reports in general and for an orphan drug in particular
Policies 0070 and 0043: Juggling different requirements
Clinical data publication by the EMA: The challenges facing the pharmaceutical industry
Clinical trial results disclosure on ClinicalTrials.gov and EudraCT
Writing lay summaries: What medical writers need to know
Lay titles for clinical trials: A balancing act
Why clinical study reports really matter
CORE Reference – a tool for modern clinical study reports in an era of increasing transparency and disclosure
Preparing clinical study reports for external sharing
Harmonising format and style requirements for scientific and medical publications
News from the EMA
Winners of the Geoff Hall Scholarship Essay Competition
Creative medical writing: An oxymoron?
Creative medical writing - An oxymoron?
An interview with Chris Winchester
Journal Watch
In the Bookstores
Good Writing Practice
Medical Devices
Getting Your Foot in the Door
Out on Our Own
Upcoming issues ofMedical Writing

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: